CRYSTAL TAYLOR: Open Payments
NPI 1134437411 · BAXTER SPRINGS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 29 payments from 7 companies in 2025. Trend: 2023 $154 · 2024 $399 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $206 |
| AstraZeneca Pharmaceuticals LP | 6 | $147 |
| Lilly USA, LLC | 3 | $53 |
| Astellas Pharma US Inc | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Amgen Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
Products named: VRAYLAR, BREZTRI, QULIPTA, MOUNJARO, Veozah, JOURNAVX, AIRSUPRA, EVENITY.
Industry payments across KS — which companies pay providers there.
